Comparison of type-specific human papillomavirus data from self and clinician directed sampling (Q30988600)

28 June 2017

Comparison of type-specific human papillomavirus data from self and clinician directed sampling (English)

1 reference

28 June 2017

5

Anna Giuliano

1 reference

28 June 2017

Susie Baldwin

1

1 reference

28 June 2017

Carlos Santos

2

1 reference

28 June 2017

Elena Mendez Brown

3

1 reference

28 June 2017

Thomas Nuño

4

1 reference

28 June 2017

John Davis

6

1 reference

28 June 2017

Francisco Garcia

7

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

28 June 2017

1 reference

28 June 2017

97

1 reference

28 June 2017

2

1 reference

28 June 2017

612-617

1 reference

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Cancer statistics for Hispanics, 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

A population-based study of vaginal human papillomavirus infection in hysterectomized women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.001

10.1016/J.YGYNO.2005.02.001

7 January 2021

Identifiers

DOI

1 reference

28 June 2017

1 reference